Prenatal therapeutics and programming of cardiovascular function

Lesley J. Brennan, Styliani Goulopoulou, Stephane L. Bourque

Research output: Contribution to journalReview articleResearchpeer-review

Abstract

Cardiovascular diseases (CVD) are a leading cause of mortality worldwide. Despite recognizing the importance of risk factors in dictating CVD susceptibility and onset, patient treatment remains a challenging endeavor. Increasingly, the benefits of prevention and mitigation of risk factors earlier in life are being acknowledged. The developmental origins of health and disease posits that insults during specific periods of development can influence long-term health outcomes; this occurs because the developing organism is highly plastic, and hence vulnerable to environmental perturbations. By extension, targeted therapeutics instituted during critical periods of development may confer long-term protection, and thus reduce the risk of CVD in later life. This review provides a brief overview of models of developmental programming, and then discusses the impact of perinatal therapeutic interventions on long-term cardiovascular function in the offspring. The discussion focuses on bioactive food components, as well as pharmacological agents currently approved for use in pregnancy; in short, those agents most likely to be used in pregnancy and early childhood.

Original languageEnglish
Pages (from-to)261-272
Number of pages12
JournalPharmacological Research
Volume139
DOIs
StatePublished - 1 Jan 2019

Fingerprint

Embryonic and Fetal Development
Cardiovascular Diseases
Pregnancy
Disease Susceptibility
Health
Plastics
Therapeutics
Pharmacology
Food
Mortality

Keywords

  • Cardiovascular function
  • Developmental programming
  • Oxidative stress
  • Therapeutics

Cite this

Brennan, Lesley J. ; Goulopoulou, Styliani ; Bourque, Stephane L. / Prenatal therapeutics and programming of cardiovascular function. In: Pharmacological Research. 2019 ; Vol. 139. pp. 261-272.
@article{ca1618c589f944338041b2039b7d9838,
title = "Prenatal therapeutics and programming of cardiovascular function",
abstract = "Cardiovascular diseases (CVD) are a leading cause of mortality worldwide. Despite recognizing the importance of risk factors in dictating CVD susceptibility and onset, patient treatment remains a challenging endeavor. Increasingly, the benefits of prevention and mitigation of risk factors earlier in life are being acknowledged. The developmental origins of health and disease posits that insults during specific periods of development can influence long-term health outcomes; this occurs because the developing organism is highly plastic, and hence vulnerable to environmental perturbations. By extension, targeted therapeutics instituted during critical periods of development may confer long-term protection, and thus reduce the risk of CVD in later life. This review provides a brief overview of models of developmental programming, and then discusses the impact of perinatal therapeutic interventions on long-term cardiovascular function in the offspring. The discussion focuses on bioactive food components, as well as pharmacological agents currently approved for use in pregnancy; in short, those agents most likely to be used in pregnancy and early childhood.",
keywords = "Cardiovascular function, Developmental programming, Oxidative stress, Therapeutics",
author = "Brennan, {Lesley J.} and Styliani Goulopoulou and Bourque, {Stephane L.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.phrs.2018.11.022",
language = "English",
volume = "139",
pages = "261--272",
journal = "Pharmacological Research",
issn = "1043-6618",
publisher = "Academic Press Inc.",

}

Prenatal therapeutics and programming of cardiovascular function. / Brennan, Lesley J.; Goulopoulou, Styliani; Bourque, Stephane L.

In: Pharmacological Research, Vol. 139, 01.01.2019, p. 261-272.

Research output: Contribution to journalReview articleResearchpeer-review

TY - JOUR

T1 - Prenatal therapeutics and programming of cardiovascular function

AU - Brennan, Lesley J.

AU - Goulopoulou, Styliani

AU - Bourque, Stephane L.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Cardiovascular diseases (CVD) are a leading cause of mortality worldwide. Despite recognizing the importance of risk factors in dictating CVD susceptibility and onset, patient treatment remains a challenging endeavor. Increasingly, the benefits of prevention and mitigation of risk factors earlier in life are being acknowledged. The developmental origins of health and disease posits that insults during specific periods of development can influence long-term health outcomes; this occurs because the developing organism is highly plastic, and hence vulnerable to environmental perturbations. By extension, targeted therapeutics instituted during critical periods of development may confer long-term protection, and thus reduce the risk of CVD in later life. This review provides a brief overview of models of developmental programming, and then discusses the impact of perinatal therapeutic interventions on long-term cardiovascular function in the offspring. The discussion focuses on bioactive food components, as well as pharmacological agents currently approved for use in pregnancy; in short, those agents most likely to be used in pregnancy and early childhood.

AB - Cardiovascular diseases (CVD) are a leading cause of mortality worldwide. Despite recognizing the importance of risk factors in dictating CVD susceptibility and onset, patient treatment remains a challenging endeavor. Increasingly, the benefits of prevention and mitigation of risk factors earlier in life are being acknowledged. The developmental origins of health and disease posits that insults during specific periods of development can influence long-term health outcomes; this occurs because the developing organism is highly plastic, and hence vulnerable to environmental perturbations. By extension, targeted therapeutics instituted during critical periods of development may confer long-term protection, and thus reduce the risk of CVD in later life. This review provides a brief overview of models of developmental programming, and then discusses the impact of perinatal therapeutic interventions on long-term cardiovascular function in the offspring. The discussion focuses on bioactive food components, as well as pharmacological agents currently approved for use in pregnancy; in short, those agents most likely to be used in pregnancy and early childhood.

KW - Cardiovascular function

KW - Developmental programming

KW - Oxidative stress

KW - Therapeutics

UR - http://www.scopus.com/inward/record.url?scp=85057241707&partnerID=8YFLogxK

U2 - 10.1016/j.phrs.2018.11.022

DO - 10.1016/j.phrs.2018.11.022

M3 - Review article

VL - 139

SP - 261

EP - 272

JO - Pharmacological Research

JF - Pharmacological Research

SN - 1043-6618

ER -